A randomised controlled trial to determine the efficacy of two different corticosteroid injections in the treatment of interdigital neuromas of the foot
| ISRCTN | ISRCTN97845378 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN97845378 |
| Secondary identifying numbers | CC 04 01 |
- Submission date
- 02/12/2004
- Registration date
- 27/04/2005
- Last edited
- 28/07/2017
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Musculoskeletal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Mr Paul Bewick
Scientific
Scientific
Podiatric Surgery Department
Stafford Central Clinic
North Walls
Stafford
ST16 3AE
United Kingdom
| Phone | +44 (0)1785 256323 |
|---|---|
| Paul.bewick@ssh-tr.nhs.uk |
Study information
| Study design | Randomised controlled trial |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised controlled trial |
| Study setting(s) | Not specified |
| Study type | Treatment |
| Scientific title | A randomised controlled trial to determine the efficacy of two different corticosteroid injections in the treatment of interdigital neuromas of the foot |
| Study objectives | To determine the efficacy of two different corticosteroid injections in the treatment of interdigital neuromas of the foot. |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Interdigital neuromas of the foot |
| Intervention | Comparison of the efficacy of the following injections administered into the affected interdigital space of the foot: 1. Betamethasone 4 mg and mepivacaine 3% 2. Depomedrone 80 mg and mepivacaine 3% 3. Mepivacaine 3% as a control |
| Intervention type | Drug |
| Pharmaceutical study type(s) | |
| Phase | Not Applicable |
| Drug / device / biological / vaccine name(s) | Betamethasone, mepivacaine, depomedrone |
| Primary outcome measure | Not provided at time of registration |
| Secondary outcome measures | Not provided at time of registration |
| Overall study start date | 01/04/2000 |
| Completion date | 31/05/2005 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Not Specified |
| Sex | Not Specified |
| Target number of participants | Not provided at time of registration |
| Key inclusion criteria | Patients presenting with clinical signs of interdigital neuromas of the foot. |
| Key exclusion criteria | Not provided at time of registration |
| Date of first enrolment | 01/04/2000 |
| Date of final enrolment | 31/05/2005 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
Stafford Central Clinic
Stafford
ST16 3AE
United Kingdom
ST16 3AE
United Kingdom
Sponsor information
Cannock Chase Primary Care Trust (UK)
Hospital/treatment centre
Hospital/treatment centre
Block D
Beecroft Court
Beecroft Road
Cannock
WS11 1JP
England
United Kingdom
| Phone | +44 (0)1543 465100 |
|---|---|
| Roger.whittaker@ssh-tr.nhs.uk |
Funders
Funder type
Government
Cannock Chase Primary Care Trust (UK)
No information available
Results and Publications
| Intention to publish date | |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Not provided at time of registration |
| Publication and dissemination plan | Not provided at time of registration |
| IPD sharing plan |
Editorial Notes
28/07/2017: No publications found in PubMed, verifying study status with principal investigator.
